The project will analyze health data and physiological insights from Whoop wearable devices, through its Unite platform, to identify new treatments that can relieve stressors for people experiencing addiction issues.
“This research leveraging Whoop Unite insights lays the groundwork for incorporating biometric assessments into routine care and, ultimately, creating a precision medicine model for addiction treatment,” said Andrew Huhn, PhD, an associate professor of psychiatry and behavioral science at Baltimore-based Johns Hopkins Medicine who is overseeing the study with Ashley patients, in a Nov. 10 news release from Whoop and Ashley.
Separately, Whoop also hired its first chief medical officer, Patrick Carroll, MD, who previously served in the same role with virtual health company Vida Health, telehealth firm Hims & Hers, and Walgreens.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
